tiprankstipranks
Advertisement
Advertisement
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
PremiumRatingsZai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
2M ago
Zai Lab Earnings Call: Growth, Pipeline And Volatility
Premium
Company Announcements
Zai Lab Earnings Call: Growth, Pipeline And Volatility
2M ago
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
Premium
The Fly
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
2M ago
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
PremiumCompany AnnouncementsZai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
3M ago
Zai Lab price target lowered to $39 from $46 at JPMorgan
Premium
The Fly
Zai Lab price target lowered to $39 from $46 at JPMorgan
3M ago
Zai Lab initiated with a Buy at UBS
Premium
The Fly
Zai Lab initiated with a Buy at UBS
4M ago
Zai Lab doses first patient in ZL-1503 trial
PremiumThe FlyZai Lab doses first patient in ZL-1503 trial
5M ago
Zai Lab announces updates to China’s National Reimbursement Drug List
Premium
The Fly
Zai Lab announces updates to China’s National Reimbursement Drug List
5M ago
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
Premium
Company Announcements
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100